Escherichia coli-specific CXCL13-producing TFH are associated with clinical efficacy of neoadjuvant PD-1 blockade against muscle-invasive bladder cancer

Published 2022 View Full Article

Authors

Keywords

Journal

Cancer Discovery

Volume -, Issue -, Pages -

Publisher

American Association for Cancer Research (AACR)

Online

2022-08-05

DOI

10.1158/2159-8290.cd-22-0201

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Cancer Discovery

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Create your own webinar